Member Info for lostinspace69

Fundamentally, we don’t have any idea how much gold is in the ground, at least until the maiden resource estimate is published. So I guess you could argue that the valuation is subjective until such time as the discovery is quantified, and therefore not surprisingly that the price dips when the market gets nervous. Hold for gold

Someone’s clearly selling. I guess we will find out soon enough. Hold for gold

If Plateau turns out to be a cookie cutter of Mt Wright, then we are sitting on min 1.5m oz of gold. Any thoughts on what that might mean in terms of valuation?

Canute40 - just watched the youtube video. really interesting and fascinating. frequency of testing is clearly the critical factor. test test test.

Canute40 - apologies, I didn't realise it had been discussed already as I don't get to read the forum every day. I am interested to know what the general consensus was on the competition. Was the general view that we are still the front runner for low cost POC antigen test?

This document is a MUST read for all Avacta investors

https://www.rockefellerfoundation.org/wp-content/uploads/2020/07/National-Covid-19-Testing-and-Tracing-Action-Plan-Full-Update-Report.pdf

The National Institutes of Health (NIH) Rapid
Acceleration of Diagnostics (RADx) will bring
to market accurate, fast, easy-to-use, and
widely accessible Covid-19 testing to enable
the nation to safely return to normal life. The
goal is to make making millions of tests per
week available in time for the 2020–2021
flu season for Americans, particularly those
most vulnerable to or disproportionately
impacted by Covid-19.

Fortunately, convenient, rapid, appropriate,
accurate, and affordable tests are on the
horizon. For example, there are more than a
dozen promising antigen tests in development
that will provide results in 30 minutes or less.
The good news is that we are in the midst of
an unprecedented boom in companies around
the world scrambling to design the best test
for Covid-19.

Point of care (POC) or point of services (POS)
tests suitable for large-scale screening are
beginning to come onto the market. New tests
and collection methods often meet initial
skepticism, as did saliva testing. Saliva was an
unconventional but desirable alternate to the
dreaded nasopharyngeal swab. Initially considered unreliable, the saliva test is showing
increased reliability and may be superior to
the nasal swab, especially in the early stages
of the disease.19 As more saliva tests are developed and validated, it may be an ideal test for
hospitality and other settings where non-invasive DIY tests are needed.

Amazon
Will begin with a self-administered pilot
testing program with an aim of testing all
employees every two weeks. Plans to spend
$4 billion on Covid-19 -related expenses,
including developing its own diagnostic labs.

National testing capacity should
expand to at least 30 million tests
a week by November, including at
least 25 million screening tests and
5 million diagnostic tests a week

Congress
needs to approve the proposed
$75 billion in additional federal
funds to cover testing costs into
next year as well as to incentivize
test development and production

Getting to three million tests a week was
essentially a framing exercise. Ramping up to
a number 10 times that high and higher will
require breakthroughs in testing technology;

oversee and goad the production
and distribution of mass quantities of fast, lowcost antigen tests. What we need to implement
a mass screening program are simple, quick,
easy and inexpensive tests. These sort of tests
are on the horizon, but getting them into the
hands of everyone who needs them – schools,
employers, health providers, public essential
workers, vulnerable communities – will require
the muscle that only the federal government
can provide

The national testing strategy we need will
require the country to ramp up to where it can
administer at least five million diagnostic tests
and 25 million screening tests a week within
three months, with the acknowledgement that
we will need still more than that

This plan requires another
$75 billion as soon as possible, because tests
should be free and accessible to all who need
them – with extra effort to make sure low-income
and minority communities, those who are more
financially vulnerable and critical institutions like
nursing homes, schools, and community centers
are supported, and that we address the sharp
racial injustices and inequities that plague our
country. This represents the single best investment America could make in averting an even
more tragic and pending disaster.

https://www.rockefellerfoundation.org/wp-content/uploads/2020/07/National-Covid-19-Testing-and-Tracing-Action-Plan-Full-Update-Report.pdf

Page 30/31

https://www.rockefellerfoundation.org/wp-content/uploads/2020/07/National-Covid-19-Testing-and-Tracing-Action-Plan-Full-Update-Report.pdf

Page 31

great find. thanks for sharing.

muted response to what was an incredible update. be interested to see where this finishes today,